Background
Methods
Design and participants
Interventions
Health related outcomes
Flourishing
Anxiety and depressive symptoms
Resource use and costing
Direct medical and non-medical costs
Direct medical costs | Direct non-medical costs | |||
---|---|---|---|---|
Health service type | Unit | Unit cost price | km | Unit cost price |
Family doctor – standard consult | Contact | 33 | 1,1 | 3.21 |
Family doctor – mental health | Contact | 66 | 1,1 | 3.21 |
Family doctor – home visit | Contact | 50 | NA | NA |
Company doctor | Contact | 33 | 17,6 | 6.34 |
Social worker | Contact | 65 | 5 | 3.95 |
Regional mental health center | Contact | 112 | 10 | 4.90 |
Regional addiction center | Contact | 112 | 10 | 4.90 |
Independent psychologist, psychotherapist, psychiatrist | Contact | 94 | 7 | 4.33 |
Psychologist, psychotherapist, psychiatrist in hospitala | Contact | 91 | 7 | 4.33 |
Self-help group | Hour | 14 | 7 | 4.33 |
Alternative healerb | Contact | 55 | 5 | 3.95 |
Intervention costs
Analysis
Statistical analyses
Cost-effectiveness analyses
Sensitivity analysis
Results
Sample characteristics
Health effects
Costs
Baseline Mean (SD) | 0–3 months Mean (SD) | 3–6 months Mean (SD) | |
---|---|---|---|
Wait-list control group (n = 138) | |||
Direct medical costs | 637.16 (1185.66) | 620.49 (1167.22) | 462.97 (1137.84) |
Direct non-medical costs | 38.14 (61.87) | 37.50 (59.61) | 25.36 (52.71) |
Intervention costs | NA | NA | NA |
Total costs | 675.30 (1245.89) | 657.99 (1223.89) | 488.33 (1189.92) |
Self-help with email support (n = 137) | |||
Direct medical costs | 546.83 (1128.45) | 408.09 (939.50) | 478.05 (956.73) |
Direct non-medical costs | 34.07 (63.50) | 23.58 (44.69) | 27.77 (45.94) |
Intervention costs | NA | 222 | NA |
Total costs | 580.90 (1190.07) | 653.66 (982.97) | 505.82 (1001.27)a |
Cost-effectiveness: Flourishing
Flourishing | Total sample | Alternative scenarios | ||
---|---|---|---|---|
A | B | C | ||
Costs, €a | 239 | 196 | 617 | 223 |
Effect | 0.19 | 0.19 | 0.19 | 0.20 |
ICER, €b | 1245 | 1058 | 3240 | 1099 |
Distribution on the cost-effectiveness plane | ||||
1st quadrant (northeast) | 92 | 86 | 100 | 89 |
2nd quadrant (inferior: northwest) | 0 | 0 | 0 | 0 |
3rd quadrant (southwest) | 0 | 0 | 0 | 0 |
4th quadrant (superior: southeast) | 8 | 14 | 0 | 11 |
WTP ceiling, % | ||||
€ 0 | 12 | 18 | 4 | 14 |
€ 10,000 | 93 | 92 | 91 | 93 |
€ 20,000 | 97 | 97 | 96 | 97 |
€ 30,000 | 100 | 100 | 100 | 100 |
Cost-effectiveness: Anxiety and depressive symptoms
Total sample | Alternative scenarios | |||||||
---|---|---|---|---|---|---|---|---|
A | B | C | ||||||
Anxiety | Depression | Anxiety | Depression | Anxiety | Depression | Anxiety | Depression | |
Costs, €a | 239 | 239 | 196 | 196 | 617 | 617 | 223 | 223 |
Effect | 0.22 | 0.21 | 0.22 | 0.21 | 0.22 | 0.21 | 0.26 | 0.23 |
ICER, €b | 1095 | 1189 | 883 | 940 | 2785 | 2897 | 904 | 968 |
Distribution on the cost-effectiveness plane | ||||||||
1st quadrant (northeast) | 91 | 90 | 86 | 86 | 100 | 100 | 89 | 89 |
2nd quadrant (inferior: northwest) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
3rd quadrant (southwest) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
4th quadrant (dominant: southeast) | 9 | 10 | 14 | 14 | 0 | 0 | 11 | 11 |
WTP ceiling, % | ||||||||
€ 0 | 13 | 13 | 18 | 18 | 4 | 4 | 15 | 15 |
€ 10,000 | 92 | 93 | 93 | 93 | 91 | 90 | 92 | 92 |
€ 20,000 | 97 | 97 | 97 | 97 | 97 | 96 | 97 | 97 |
€ 30,000 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |